Private Capital Group’s United Therapeutics UTHR Stock Holding History

Private Capital Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$25K	Hold	106	–	–	0.02%	754
2022 Q1	$19K	Buy	106 +79	+293%	+$15.1K	﹤0.01%	1059
2021 Q4	$6K	Sell	27 -91	-77%	-$17.9K	﹤0.01%	1507
2021 Q3	$22K	Buy	118 +94	+392%	+$18.5K	0.01%	1042
2021 Q2	$4K	Hold	24	–	–	﹤0.01%	1665
2021 Q1	$4K	Sell	24 -2	-8%	-$333	﹤0.01%	1610
2020 Q4	$4K	Buy	26 +11	+73%	+$1.44K	﹤0.01%	1630
2020 Q3	$2K	Hold	15	–	–	﹤0.01%	1759
2020 Q2	$2K	Buy	+15	New	+$1.69K	﹤0.01%	1738

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Private Capital Group's UTHR Position: Q2 2022 in Review

Private Capital Group held its United Therapeutics (UTHR) position steady in Q2 2022 at 106 shares worth $25K. The position accounts for 0.02% of the portfolio, ranked #754.

Private Capital Group first reported a position in UTHR in Q2 2020 and has held it in 9 quarters since. 473 funds tracked by Wall St. Rank hold UTHR as of Q2 2022.

Private Capital Group held 106 shares of United Therapeutics worth $25K as of Q2 2022.
Private Capital Group left its United Therapeutics share count unchanged in Q2 2022.
United Therapeutics made up 0.02% of Private Capital Group's portfolio in Q2 2022, its #754 holding.
Private Capital Group first reported a position in United Therapeutics in Q2 2020 and has held it in 9 quarters since.
473 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.